Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]ISO-1 PET/CT Imaging in Primary Breast Cancer
NCT02284919Phase 1Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Mar 2015
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of ISO-1 F-18 in breast cancer, sponsored by University of Pennsylvania. Primary endpoint: Correlation of [18F]ISO-1 uptake with Ki-67 at 6 years. Started Mar 2015; status: active, not recruiting.
02
Drugs
ISO-1 F-18
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02284919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284919.